Dopaminergic role in stimulant-induced wakefulness.
Article Details
- CitationCopy to clipboard
Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM
Dopaminergic role in stimulant-induced wakefulness.
J Neurosci. 2001 Mar 1;21(5):1787-94.
- PubMed ID
- 11222668 [ View in PubMed]
- Abstract
The role of dopamine in sleep regulation and in mediating the effects of wake-promoting therapeutics is controversial. In this study, polygraphic recordings and caudate microdialysate dopamine measurements in narcoleptic dogs revealed that the wake-promoting antinarcoleptic compounds modafinil and amphetamine increase extracellular dopamine in a hypocretin receptor 2-independent manner. In mice, deletion of the dopamine transporter (DAT) gene reduced non-rapid eye movement sleep time and increased wakefulness consolidation independently from locomotor effects. DAT knock-out mice were also unresponsive to the normally robust wake-promoting action of modafinil, methamphetamine, and the selective DAT blocker GBR12909 but were hypersensitive to the wake-promoting effects of caffeine. Thus, dopamine transporters play an important role in sleep regulation and are necessary for the specific wake-promoting action of amphetamines and modafinil.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Modafinil Sodium-dependent dopamine transporter Protein Humans YesInhibitorDetails